Top Markets
Coin of the day
Dermisonics, Inc. Dermisonics, Inc.

Dermisonics, Inc.

DMSI
Rank in Stocks #42356
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment... Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.
Share Price
$0.00003
Last synced: 2026-08-11
Market Cap
$1.92K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Dermisonics, Inc. (DMSI)

Category

Revenue for Dermisonics, Inc. (DMSI)
Revenue in Aug 2026 TTM: 0
According to Dermisonics, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dermisonics, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors